US · Basic Materials · Specialty Chemicals
EPS came in at 1.29 against a street estimate of 1.26 — a beat of 2.4%.
Analysts rate Innospec Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $101.00.
CONFIDENT Innospec delivered Q2 beats: 12% revenue growth, EPS $1.27 vs $1.05 street estimate. Performance Chemicals rebounding post-repairs (60% complete by year-end), Fuel Specialties strong despite margin headwinds, Oilfield Services surging 40% on DRA expansion. Debt-free $250M cash, positive FCF. Q2 2026 Middle East driving oilfield upside; North Carolina repairs creating Q4+ capacity bottleneck; Mexico early-stage opportunistic. Analysts pressed on repair timeline and capacity drag, raw material cost pass-through mechanics, and oilfield growth opportunities. Management acknowledged Q3 volume plateau, confirmed pricing discipline working, outlined Mexico optionality but no near-term contribution. 2026-08-05…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 17.79% |
| Allspring Global Investments Holdings, LLC | 7.68% |
| Vanguard Portfolio Management, LLC | 7.65% |
| Dimensional Fund Advisors, Inc. | 5.30% |
| Vanguard Capital Management, LLC | 4.50% |
| State Street Corp | 4.04% |
| Nuveen, LLC | 3.07% |
| Geode Capital Management, LLC | 2.71% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 net sales were $473.6 million, up from $441.9 million in the third quarter of 2025. • Third-quarter gross prof | 2026-11-04 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter revenue rose 7% year over year to $473.6 million from $441.9 million. • GAAP net income attributable to Innospec in | 2026-11-03 |
| Quarterly report · Q2 2026 INNOSPEC INC. - 10-Q SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Net Sales (6 months ended June 30, 2026): $944.6 million vs. $880.5 million in | 2026-08-05 |
| Results announced · Q3 2026 INNOSPEC INC. – Q2 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Total revenues Q2 2026: $491.4 million, up 12% from $439.7 million in Q2 2025 • Operati | 2026-08-05 |
| Board / officer change · Q2 2026 INNOSPEC INC. - 8-K FILING SUMMARY HEADLINE NUMBERS • Board size increased from 7 to 8 directors effective June 2, 2026 • New director appointment e | 2026-06-04 |
| Shareholder vote results · Q2 2026 INNOSPEC INC. (IOSP) – 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held May 8, 2026 • 22,661,185 shares present or represented by proxy out of 24, | 2026-05-13 |
| Quarterly report · Q1 2026 INNOSPEC INC. - Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Net sales Q1 2026: $453.2 million vs. $440.8 million Q1 2025 (up 2.8%) • Net income attribut | 2026-05-08 |
| Results announced · Q2 2026 INNOSPEC INC. – Q1 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Total revenues: $453.2 million, up 3% from $440.8 million in Q1 2025 • GAAP dil | 2026-05-08 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.94 / share ex-date Nov 17, 2026 · pay Nov 25, 2026 | 2026-11-17 |
| Dividend | $0.92 / share ex-date May 19, 2026 · pay May 29, 2026 | 2026-05-19 |
| Dividend | $0.87 / share ex-date Nov 18, 2025 · pay Nov 26, 2025 | 2025-11-18 |
| Announcement | Date |
|---|---|
| Annual dividend increased 9 percent and semi-annual dividend of 94 cents declared Innospec reported a strong third quarter ended September 30, 2026. Revenue rose 7% year over year to $473.6 million, while GAAP net income increased to $31.8 million, or $1.29 per diluted sh | 2026-11-03 |
| Dividend increased 10%, $75M new buyback authorization announced Innospec Inc. reported Q1 2026 results with mixed performance. Total revenues increased 3% to $453.2 million, but adjusted EPS declined significantly to $1.05 from $1.42 year-over-year—a 26% | 2026-05-08 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Innospec Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.